Dr. Adil Daud highlights the crisis in cancer research stemming from ongoing political maneuvers, such as cuts to NIH funding and confusion due to halted communication. Experts fear these shifts will prompt researchers to leave academia for more lucrative industry jobs, raising concerns about the viability of medical research careers. Notably, while lifestyle changes are acknowledged as beneficial, they are deemed insufficient for terminal cancer patients who rely on innovative treatments. The scientific community is left unsettled with uncertain implications for the future of research and public health.
"We're somewhat of an endangered species already. I bring a lot of bedside-to-bench expertise. That will be lost if people like me don't see academic medicine as a viable career path."
"We put our hearts and souls into medical research. Don't get me wrong - I make a decent salary as a physician-scientist. But I could make a lot more money if I went into industry."
"The reason why there is so much confusion in the scientific community is that there is no purported end date associated with this decision to stop some aspect of grant review and public communication."
"Experts agree lifestyle changes are important, but stress that exercise and nutrition won't be enough for terminal cancer patients who need breakthrough treatments."
Collection
[
|
...
]